IREN
IREN Limited
There isn't enough reported data to score IREN yet.
LMND
Lemonade, Inc.
There isn't enough reported data to score LMND yet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
LMND Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
LMND's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like LMND.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
LMND PE Valuation
LMND has no meaningful PE right now: it lost money over the past year.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
LMND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
LMND has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
LMND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.86 | +$0.53 |
| Q2 2026 | -$1.81 | +$1.02 |
| Q1 2026 | -$1.85 | +$1.19 |
| Q4 2025 | -$2.24 | +$0.61 |
| Q3 2025 | -$2.39 | +$0.64 |
| Q2 2025 | -$2.83 | +$0.13 |
| Q1 2025 | -$3.04 | +$0.08 |
| Q4 2024 | -$2.85 | +$0.55 |
LMND has the edge over IREN on earnings, with more consistent year-over-year improvement.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was โ82% last quarter, down 50 points from the same quarter a year ago.
LMND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $336.1M | +73% |
| Q2 2026 | $294.4M | +79% |
| Q1 2026 | $258M | +71% |
| Q4 2025 | $228.1M | +53% |
| Q3 2025 | $194.5M | +42% |
| Q2 2025 | $164.1M | +35% |
| Q1 2025 | $151.2M | +27% |
| Q4 2024 | $148.8M | +29% |
LMND's revenue has grown year over year for 21 quarters in a row: $336M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | +5.8 points |
| Q2 2026 | -14% | +12 points |
| Q1 2026 | -13% | +27 points |
| Q4 2025 | -9% | +16 points |
| Q3 2025 | -19% | +30 points |
| Q2 2025 | -26% | +19 points |
| Q1 2025 | -41% | -2.7 points |
| Q4 2024 | -25% | +8.9 points |
LMND has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was โ$2.5B over the past year, against โ$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
LMND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9M | -27% |
| Q2 2026 | -$8M | -335% |
| Q1 2026 | -$4.1M | +$45.4M |
| Q4 2025 | $17.6M | +66% |
| Q3 2025 | $2.6M | -82% |
| Q2 2025 | $3.4M | +$16.6M |
| Q1 2025 | -$49.5M | -$17.2M |
| Q4 2024 | $10.6M | +$29.1M |
LMND has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
LMND Net Leverage
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
LMND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.1 | Neutral |
| Stochastic | 9.9 | Oversold |
LMND's weekly RSI is 40 (neutral) and its Stochastic is 10 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
IREN has no meaningful PE right now: it lost money over the past year.
LMND PE vs Financial Services Sector
LMND has no meaningful PE right now: it lost money over the past year.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
LMND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.1 | 2.5% below |
| 20 week MA | $51.6 | 17% below |
| 50 week MA | $60.0 | 28% below |
| 100 week MA | $51.5 | 17% below |
| 200 week MA | $34.7 | 24% above |
LMND has fallen below most of its moving averages, though it's still 24% above its 200-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to โ93% in 2022. It's down 52% so far in 2026.
LMND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.4 | $125.1 | +80% |
| 2021 | $125.1 | $45.7 | -64% |
| 2022 | $45.7 | $14.4 | -68% |
| 2023 | $14.4 | $16.1 | +12% |
| 2024 | $16.1 | $39.4 | +144% |
| 2025 | $39.4 | $74.7 | +90% |
| 2026 YTD | $74.7 | $43.0 | -42% |
LMND has the edge over IREN on returns for 2026, with the stronger performance.